Theralase Technologies Inc. V.TLT

Interim Data...

[wildbird1]

Last year the update was on August 29,2022

The interim data for August 29,2022

            90 Day     180 Day     270 Day     360 Day    450 Day
CR           50%           47%            41%           35%          21%


The interim data for  May 31,2023
            90 Day     180 Day     270 Day     360 Day     450 Day
CR           60%          53%           43%            36%            33%
            (+20%)      (+14%)       (+5%)          (+4%)        (+55%)

The Interim data for August 29,2023???
             90 Day      180 Day     270 Day    360 Day     450 Day
                +?               +?              +?             +?             + ?
We can only predict that unlike Keytruda & Adstiladrin, it will not go down.

[Oilminerdeluxe]

Bought my, hopefully, last batch at 0.24. Any time, Roger. feel free to release the Kraken

[eibbor44]

Same, got a few more. 

[Infinity]

Frankly,  I don't expect major jump in share prices as long as Roger keeps talking about Cheap PP at $ 0.25 for his select group of buddies.  The clinical results will make a short term swing up which will be brought down as soon as RDW starts talking about his 25 cent PP.    The Pumpers and spin Doctors will continue with their expert opinion.  Nothing prophecied on

[ScienceFirst]

Funny, it's the same that now whine about small pps that were requesting them in 2016, 2017, 2018, 2019! Hey, I can even bet that once we have a deal, no matter what it is, the same ones will still whine, say this is not enough, etc ... A classic, coming from the same that clearly don't understand the environment they're invested in, when you read their posts.  Like we should

[Infinity]

Funny it is the same pumpers, coming up with their own versions and excuses for a company's track record of extending on their time lines,  Yes they had legitimate reasons in the past due to Covid.  Now there is no more reason to extend their own time lines and keep issuing PP's instead of seeking a Joint venture.  It is IMPOSIBBLE that all Major Pharma companies are

[socksnblonds642]

A JV could kill this company. That's lunacy at this stage. PP's are the best way to finance Theralase until the trials are complete. The numbers keep going the way they are Roger will have no problem going to the well. You can call him and get in on one of his PP's. BT will get the bump you need to get out. 

[Infinity]

Socks and blonds and other pumpers like sci fart may feel that ONE man show is better than a JV and that the market has valued the stock at less than 30 cents is the correct valuation for the company based on the clinical data so far.  He or She or it or they may have their own their reasons that defies all Logic for simply extending all deadlines.  Today's News report will prop the

[ScienceFirst]

Infinity ... I think you have a lot confused. A jv doesn't give control of the company to the big pharma.  Only rights to the drug, for a specific indication, as per the jv contract.  Big difference and basic concept that we should have understood. By the way, it is TLT that has decided to seek interest of big pharmas for a jv.  So Roger is not trying to withhold anything

[socksnblonds642]

To Infijity and beyond! 

[DJDawg]

Based on what is pending and how hard it can be to move the % when you have a certain number already counted, my prediction is that 90,180, 360, 450 pretty much stay the same. 270 should get a bump up based on the big wave of CR at 180 from last time. Regardless, evein if the CR doesn't change too much, you get higher statistical strength based on the enlargening sample size. e.g. 60% of 20

[wildbird1]

If you look at the last swimmer plot(May 31,2023), you will notice that, of the last 14 patients treated(90Day+), 11/14 are CR(complete Response). That is a very big 80%CR "at any point in time" for these 14 patients. For now the 450 Day CR% will not change(or very little change), but in due time some of these 11 green dots patients will eventually reflect on the 450 day CR% that will

[Eoganacht]

Yes, 270 days should get a bump. If 5 of the 6 CRs sitting at 180 days maintain their CR, the 270 CR rate should go to 49% from 43%. 360 days could go up to 38% from 36% if the 2 CRs at 270 hang on. 90 day rate will depend on how many of the 5 patients awaiting evaluation are CR. If they are all CR the rate would go up to 64% - from 60%. We'll probably know tomorrow some time after the

[Eoganacht]

270 day bump to 47% 360 day bump to 38% 90 day bump to 64% - all 5 patients awaiting evaluation were CR

[Eoganacht]

Never mind. I was looking at the optimized table...

[enriquesuave]

Pretty stable and awesome data.  270 days is looking better. especially when combining CR plus IR, and overall with optimized treatment we can see we would get about 5-10% increase in CR in the end.  So I'm expecting overall after 100 patients about 45%  CR at 450 days. It could end up higher, but  I will be happy with anything over 35%.   We are clearly over 30

[Legit62]

totally agree Enrique, it appears we are at the point of getting everything in order and our next news release will indicate we have BTD and AA with that data being so superior

[N0taP00p]

Overall, though BTD submission moved one year from their original estimate, they have for the first time clearly stated the steps to get there and the data continues to look good. If all goes well and we don't get into the holiday crush (read: key people needed to compile or approve are not available), we should have BTD by the end of the year. My gut says mid Q1. Maybe another pharma notices

[Alamir1111]

Enrolment patients is  4  in for months at 7 clinics?

[jmm1228]

Nota - you took the words right out of my mouth!

[BudFoxx2020]

Just as I predicted what you will do and say.   Are you playing the role of the bad guy to Sciencefirst good guy.   Now the narrative changes to 2024.  The only thing that is exciting here is if we ever find out who Sciencefirst aka bencro is.  If he is a employee or a third party and how much he was compensated for the last 15 to 20 years pumping this stock 24/7 non

[Donein25]

Budd, name me one other company that is currently working with the FDA on BTD?  Good bye Budd. 

[Impalaman]

I noticed that there will be over 4 million warrants coming due on the 9th of january 2024---priced at--0.50---hopefully we get BTD just before---GLTA.

[chry200030]

4 million is p-nuts..

[Impalaman]

Better then a kick in the---nuts.

[N0taP00p]

The kick in the g0nads will come when they file for the next PP. Probably in a few weeks. Unless they have something lined up which I doubt

[Eoganacht]

Yes sir. Stable and awesome and on our way to even better results. Hopefully we see BTD by year end and AA soon after.

[Legit62]

Eoganacht, not only are our CR% getting better but our safety profile is phenominal, the adverse affects are minimal, which i bbelieve will be a huge boost for BTD and AA approval within a short period of each other, they are just getting all the data in order for proper presentation then we are off to the races. Would like to see an uptick in share volume which will get us back into the .30s